A model fund? Five-step guide to explore possible funding for lower-priority drug trials

In this article, Ben van der Schaaf, principal at Arthur D. Little, gives a five-step guide to explore possible funding partnerships for lower-priority drug trials — a new model for big pharma. Read more

2 Aug 2017 10:49 Ben van der Schaaf Opinion